effect of Haridra churna bidalak in krimigranthi (blepharitis)

A randomised controlled clinical trial to study the effect of haridra churna bidalak in management of krimigranthi with special reference to blepharitis. - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/05/086649

Enrollment

Registered

2025-05-09

Start date

Unknown

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H010- Blepharitis

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients having clinical sign and symptoms of krimigranthi . 2.Patients were selected irrespective to age, sex, religion, cast, occupation, socioeconomic status. 3.Age between 25-60 years. 4.Patients fit for Treatment. 5.Patient who will give written consent for treatment

Exclusion criteria

Exclusion criteria: 1.Associated with psoriasis and any other skin disease. 2.Patient suffering from cataract, severe illness like DM ,TB, HIV, HBSAG . 3.Patient suffering with complications of Blepharitis such as Madarosis, Conjuctivities, Marginal Keratitis, Trichiasis. 4. Below 25 and above 60 years of age patients not included in study

Design outcomes

Primary

Measure	Time frame
Reduction in sign and symptoms of krimigranthi after application of haridra churna bidalak.Timepoint: 7 days	—

Secondary

Measure	Time frame
Where the trial group stands in comparison with control group in reduction with sign and symptoms of Blepharitis.Timepoint: 18 months	—

Countries

India

Contacts

Public ContactDr Priya Nitin Salve

OPD NO 16 Shalakyatantra Department, SMBT Ayurved College and Hospital, Dhamangaon, Igatpuri, Nashik

petalsayu@gmail.com9850447661

Outcome results